Search
The COPD Blues: A Guide to Optimizing Outpatient Management
For the 30 million adults in the U.S. with COPD, effective care requires providers to have an up-to-date understanding of treatment options as well as the ability to respond to changes in a patient’s status.New Perspectives on Persistent Opioid Dependence: Reasons Patients Struggle, Routes to Better Care
Pain medicine specialist Chris R. Abrecht, MD, explains why the clinical focus on the physical pain of opioid withdrawal may be hampering effective treatmentUCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the world came together for the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest developments in cancer care, research, technology and education.Are New Therapies on the Horizon for Painful Skin Condition?
UCSF Health leads multi-center study of chronic inflammation of the skin that affects women and people of color disproportionately.Prominent Orthopaedic Surgeon and Researcher to Lead UCSF Orthopaedics Program
C. Benjamin Ma, MD, a highly regarded orthopaedic surgeon and advanced imaging researcher, has been appointed as chair of the UCSF Department of Orthopaedic Surgery. Ma assumed his new role on January 1, 2024.Prostate Cancer Test Is Missing Early Disease in Transgender Women
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC San Francisco.One Gene Variant Is Poised to Cure Devastating COPA Syndrome
Scientists compared five families and multiple generations to find a gene variant that prevents COPA Syndrome and opens the door to a new gene therapy for the condition.UCSF Awarded $12M Research Grant to Improve Cancer Outcomes
SPORE Grant from National Cancer Institute provides resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes.AI in Cancer Care, Targeted Therapies Among Cancer Conference Talks
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat cancers and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference.Prioritizing Organ Preservation for Rectal Cancer Patients
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required.Using AI to Improve Detection of Rare Diseases
Acute hepatic porphyria (AHP) is a rare genetic disease with symptoms that overlap with many other conditions, making it extremely challenging to diagnose. Its symptoms mostly affect women with severe, sometimes life-threatening attacks that include abdominal pain, nausea, vomiting, limb weakness and anxiety.Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.Dry Days Ahead: Effective Strategies for Common Urinary Complaints
While stress incontinence and overactive bladder may not be life-threatening, they can be life-diminishing. Yet, with the stepped care approach presented by urologic surgeon Anne M. Suskind, MD, MS, FACS, clinicians can find a remedy to help almost any patient.UCSF Among First in U.S. to Receive New Pulmonary Care Designation
UCSF has been designated a Bronchiectasis and NTM Care Center, based on the depth and breadth of its services.How We Could Test for Unhealthy Alcohol Use Before It's Too Late
A new study finds that a blood test may be a more reliable indicator of liver disease than asking how much a person drinks.Incidental Thyroid Nodules: Benign Bump or Big Deal?
A lump on the thyroid is a common finding in both physical exams and imaging studies, but the significance varies greatly.Treating Brain Aneurysms: How a Savvy Neurosurgical Team Individualizes Care
In this short video, vascular and endovascular surgeon Ethan Winkler, MD, PhD, explains the factors that go into determining the right treatment for different cases involving dangerously bulging blood vessels in the brain.New Treatment Framework for Anti-Amyloid Therapies Developed by UCSF-led Alzheimer’s Association Consortium
A breakthrough treatment in the fight against Alzheimer’s disease is a class of therapies called anti-amyloid antibodies (anti-A?). These monoclonal antibodies – proteins made in a laboratory intended to stimulate the immune system – have been shown to slow the progression of the disease by targeting amyloid plaques in the brain that are characteristic of Alzheimer’s.Gender Affirming Care, Perinatal Innovation Among Obstetrics and Gynecology Conference Talks
Innovations in perinatal care, gender affirming care and improving pregnancy outcomes for women with fibroids, were among the topics UCSF clinicians discussed at the American College of Obstetricians and Gynecologists (ACOG) 2024 Annual Clinical & Scientific MeetingStephen Hauser Wins Breakthrough Prize for Role in Redefining MS
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.